We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$231B
AUM Growth
+$33B
Cap. Flow
+$7.99B
Cap. Flow %
3.46%
Top 10 Hldgs %
20.51%
Holding
6,891
New
816
Increased
2,304
Reduced
2,388
Closed
883

Sector Composition

Rank Sector Weight
1 Technology 8.34%
2 Healthcare 6.09%
3 Financials 5%
4 Consumer Discretionary 4.53%
5 Industrials 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPAL icon
6301
OPAL Fuels
OPAL
$64.4M
-16,128
Closed -$132K
OPEN icon
6302
PUT
Opendoor
OPEN
$3.43B
-530,513
Closed -$1.36M
ORIC icon
6303
Oric Pharmaceuticals
ORIC
$1.47B
-1,163,760
Closed -$7.04M
OVLY icon
6304
Oak Valley Bancorp
OVLY
$291M
-10,463
Closed -$262K
OWLT icon
6305
Owlet
OWLT
$152M
-13,384
Closed -$60K
OXLC
6306
Oxford Lane Capital
OXLC
$906M
-3,782
Closed -$94.4K
PACB icon
6307
Pacific Biosciences
PACB
$420M
-153,717
Closed -$1.26M
PATH icon
6308
PUT
UiPath
PATH
$8.49B
-107,600
Closed -$1.84M
PAVM icon
6309
PAVmed
PAVM
$41.4M
-73
Closed -$9.69K
PBYI icon
6310
CALL
Puma Biotechnology
PBYI
$477M
-200,000
Closed -$526K
PCN
6311
PIMCO Corporate & Income Strategy Fund
PCN
$869M
-11,358
Closed -$138K
PCRX icon
6312
Pacira BioSciences
PCRX
$983M
-49,921
Closed -$1.53M
PCSA icon
6313
Processa Pharmaceuticals
PCSA
$5.81M
-52
Closed -$6.61K
PCTY icon
6314
Paylocity
PCTY
$8.14B
-98,296
Closed -$17.9M
PCY icon
6315
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
-26,849
Closed -$491K
PCYO icon
6316
Pure Cycle
PCYO
$273M
-44,310
Closed -$425K
PD icon
6317
CALL
PagerDuty
PD
$950M
-100,000
Closed -$2.25M
PDBC icon
6318
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.06B
-150,000
Closed -$2.24M
PDT
6319
John Hancock Premium Dividend Fund
PDT
$620M
-19,608
Closed -$189K
PEBO icon
6320
Peoples Bancorp
PEBO
$1.44B
-8,065
Closed -$205K
PEG icon
6321
PUT
Public Service Enterprise Group
PEG
$36.2B
-5,800
Closed -$330K
PED icon
6322
PEDEVCO
PED
$184M
-1,255
Closed -$25.4K
PEN icon
6323
PUT
Penumbra
PEN
$12.8B
-10,200
Closed -$2.47M
PFG icon
6324
PUT
Principal Financial Group
PFG
$23.7B
-15,200
Closed -$1.1M
PFN
6325
PIMCO Income Strategy Fund II
PFN
$687M
-47,692
Closed -$314K

Similar funds

Israel Englander's Q4 2023 Portfolio in Review

As of Q4 2023, Israel Englander held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Israel Englander deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.

  • Israel Englander's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
  • Israel Englander's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
  • Israel Englander fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
  • Israel Englander's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
  • Israel Englander opened 816 new positions and closed 883 in Q4 2023.
  • Israel Englander's portfolio value rose 17% quarter-over-quarter to $231B.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.